Profile of the Hepatocellular Carcinoma Patients in Turkey
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Hepatocellular Carcinoma
Both
Hepatocellular Carcinoma
Trial Information
Profile of the Hepatocellular Carcinoma Patients in Turkey
Inclusion Criteria:
- To be diagnosed with hepatocellular carcinoma in last 3 months
- To be older than 18 years old
- To sign informed consent form (ICF)
Exclusion Criteria:
- Patients that does not sign or withdraw informed consent form.
- According to investigator's opinion; existence of any situation/condition that will
significantly complicate patient follow up.
- Currently or previously taking part in 3K observational study
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Outcome Measure:
Duration of treatment for chemotherapy and systemic treatment
Outcome Time Frame:
Every 3 months
Safety Issue:
Yes
Principal Investigator
Bayer Study Director
Investigator Role:
Study Director
Investigator Affiliation:
Bayer
Authority:
Turkey: Ministry of Health General Directorate of Pharmaceuticals and Pharmacy
Study ID:
15807
NCT ID:
NCT01473121
Start Date:
August 2012
Completion Date:
October 2016
Related Keywords:
- Hepatocellular Carcinoma
- Hepatocellular carcinoma
- Registry
- Turkey
- Carcinoma
- Carcinoma, Hepatocellular
Name | Location |
|---|
